Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Influence of Syringe Volume on Foam Stability in Sclerotherapy for Varicose Vein Treatment

Bai, Taoping, MS*; Jiang, Wentao, PhD*; Fan, Yubo, PhD

doi: 10.1097/DSS.0000000000001402
Original Article

BACKGROUND Despite the popularity of sclerotherapy for treating varicose veins, it still exhibits various problems, such as pulmonary embolism, deep-vein thrombosis, phlebitis, and visual disorders.

OBJECTIVE To investigate syringe volume influence on foam stability, obtain the foam decay rule, and provide a reference for clinics.

MATERIALS AND METHODS Five types of syringes are used to prepare foam at room temperature with various liquid–gas ratios. Foam decay process experiments were performed 5 times and recorded by video. The stability indices used include drainage time, half-life, bubble diameter, bubble surface density, and drainage rate.

RESULTS The 30 and 2-mL syringes, respectively, recorded the highest and lowest drainage speeds. Foam drainage time and half-life, differences varied between 15 and 70 seconds, and 20 and 100 seconds, respectively. Foam bubble diameters were distributed over 0.1 to 2.0 mm with roughly 200 to 700 bubbles per square centimeter.

CONCLUSION Increased syringe volume causes the bubble diameter to increase. Thus, foam dispersion increases and foam half-life decreases; hence, foam becomes unstable. It is, thus, better to use a small syringe several times to prepare foam in clinics using segmented injections.

*Department of Applied Mechanics, Sichuan University, Chengdu, China;

Bioengineering Department, School of Biological Science and Medical Engineering, Beihang University, Beijing, China

Address correspondence and reprint requests to: Wentao Jiang, PhD, Department of Applied Mechanics, Sichuan University, NanYihuan Road No. 24, WuHou District, Chengdu 610065, China, or e-mail:

The authors have indicated no significant interest with commercial supporters.

© 2018 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website